TXMD TherapeuticsMD: Net earnings per share for the last 12 months

Official company branding of TherapeuticsMD Inc (TXMD)

The current annual growth rate of EPS TTM for TherapeuticsMD, Inc. (TXMD) demonstrates management's efforts to stabilize the business model. The foundation consists of implementing sustainable ESG standards into drug development and optimizing energy costs. Efficiency is supported by a streamlined distribution network through pharmacy chains, which eliminates product shortages. Meanwhile, -59.80 serves as the current parameter value, capturing the earnings per share dynamics adjusted for operating expenses.

TherapeuticsMD Inc (TXMD): Earnings per share for the last twelve months from 02/11/2024 to 11/18/2026

TherapeuticsMD - analytical breakdowns and key metrics (TXMD)

- price and consensus price forecast:
Fundamental company valuation:TXMD, TherapeuticsMD Corp
Manufactured products of therapeuticsmd.com

This indicator measures the dynamics of the rolling annual earnings per share, allowing for the filtering of market noise to assess the real impact of monetary factors on the pace of business capitalization. By analyzing the year-over-year EPS (TTM) comparison, an investor can determine how effectively TherapeuticsMD, Inc. (TXMD) maximizes royalties during its operational adaptation period, which defines the company's ultimate fundamental stability.